End-stage renal disease and drug-eluting stents: One small step forward

Journal of Invasive Cardiology

Volumn 18, Issue 9, 2006, Pages 409-410

  Gruberg, Luis ^a   Beyar, Rafael ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIALYSIS; DRUG ELUTING STENT; HUMAN; KIDNEY FAILURE; MORBIDITY; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR DISEASES; CORONARY RESTENOSIS; HUMANS; INFUSION PUMPS, IMPLANTABLE; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RENAL DIALYSIS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 33748743795     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Note

References (16)

1. Lindner A, Charra B, Sherrad DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Hellerstedt WL, Johnson WJ, Ascher N, et al. Survival rates of 2728 patients with end stage renal disease. Mayo Clin Proc 1984;59:776-783.
3. Gokal R, King J, Bogle S, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: 4-Year analysis and prospective multicenter study. Lancet 1987;ii:1105-1109.
4. Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, April 1997, pp. 91-101 (NIH publication no. 97-3176).
5. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996;77:158-165.
6. Rinehart AL, Herzog CA, Collins AJ, et al. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995;25:281-290.
7. Owen CH, Cummings RG, Sell TL, et al. Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thoracic Surg 1994;58:1729-1733.
8. Ko W, Kreiger KH, Isom OW. Cardiopulmonary bypass procedures in dialysis patients. Ann Thoracic Surg 1993;55:677-684.
9. Koyanagi T, Nishida H, Kitamura M, et al. Comparison of clinical outcomes of coronary artery bypasses grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thoracic Surg 1996; 61:1793-1796.
10. Venkatesan J, Henrich WL. Cardiac disease in chronic uremia: Management. Adv Ren Replace Therapy 1997;4:249-266.
11. Gruberg L, Dangas G, Mehran R, et al. Clinical outcome following percutaneous interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002;55:66-72.
12. Gruberg L, Rai P, Mintz GS, et al. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 2005;96:892-896.
13. Gruberg L, Weissman NJ, Waksman R, et al. Comparison of outcomes of percutaneous coronary revascularization with stents in patients with and without mild chronic renal failure. Am J Cardiol 2002;89:54-57.
14. Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-305.
15. Das P, Moliterno D, Charnigo R, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006;18:405-408.
16. Lemos PA, Arampatzis CA, Hoye A, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents of bare metal stent. Am J Cardiol 2005; 95:167-172.